000			01923 a2200589 4500
005			20250517123659.0
264		0	_c20180222
008			201802s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.13083 _2doi
040			_aNLM _beng _cNLM
100	1		_aHu, Yingwen
245	0	0	_aSequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier. _h[electronic resource]
260			_bOncotarget _cDec 2016
300			_a83258-83269 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdsorption
650	0	4	_aAntineoplastic Agents _xchemistry
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aCell Cycle Checkpoints _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aChitosan _xanalogs & derivatives
650	0	4	_aDisulfides _xchemistry
650	0	4	_aDrug Compounding
650	0	4	_aDrug Liberation
650	0	4	_aFemale
650	0	4	_aGene Transfer Techniques
650	0	4	_aHumans
650	0	4	_aHydrophobic and Hydrophilic Interactions
650	0	4	_aMCF-7 Cells
650	0	4	_aNanoconjugates
650	0	4	_aNanomedicine
650	0	4	_aOxazines _xchemistry
650	0	4	_aPaclitaxel _xchemistry
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aRNA Interference
650	0	4	_aRNA, Small Interfering _xchemistry
650	0	4	_aRNAi Therapeutics _xmethods
650	0	4	_aStatic Electricity
650	0	4	_aStearic Acids _xchemistry
650	0	4	_aSurface Properties
650	0	4	_aTime Factors
650	0	4	_aTransfection
700	1		_aLiu, Na
700	1		_aCheng, Bolin
700	1		_aTan, Yanan
700	1		_aWen, Lijuan
700	1		_aYuan, Hong
700	1		_aHu, Fuqiang
773	0		_tOncotarget _gvol. 7 _gno. 50 _gp. 83258-83269
856	4	0	_uhttps://doi.org/10.18632/oncotarget.13083 _zAvailable from publisher's website
999			_c26587356 _d26587356